Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

2.13
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
1.55
Today|||52-Week Range
5.75
-18.27%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Perceptive Advisors Llc
Sale6/19/2017875,000$2.40$2.1M-15.00%
Edwards Mark G
Director
Buy11/14/201730,000$1.90$57.0K+14.86%
Hamel Lawrence G
Chief Development Officer
Sale10/02/201710,161$5.29$53.8K-61.36%
Dasu Badri N
Chief Engineering Officer
Buy10/19/201737,500$1.20$45.0K+21.43%
Angotti Vincent J
Chief Executive Officer
Buy8/24/201715,000$3.00$45.0K-28.57%
Palmer Pamela Pierce
Chief Medical Officer
Buy8/22/201710,000$2.95$29.5K-27.97%
Asadorian Raffi
Chief Financial Officer
Buy9/11/20177,000$3.24$22.7K-33.59%
Edwards Mark G
Director
Buy8/24/20174,800$3.02$14.5K-28.57%
Hamel Lawrence G
Chief Development Officer
Gift4/10/20179,122$1.20$10.9K-22.73%
Asadorian Raffi
Chief Financial Officer
Buy11/13/20175,000$1.94$9.7K+11.84%
Page of 2